These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 26817176)
1. Reliability of Thai-Version Overactive Bladder Symptom Scores (OABSS) Questionnaire and the Correlations of OABSS with Voiding Diary, International Prostate Symptom Score (IPSS), and Patient Perception of Bladder Condition (PPBC) Questionnaires. Bunyavejchevin S J Med Assoc Thai; 2015 Nov; 98(11):1064-74. PubMed ID: 26817176 [TBL] [Abstract][Full Text] [Related]
2. Test - retest reliability of the Indonesian version of the Overactive Bladder Symptom Score (OABSS) and its correlation with standard assessment tools. Sumardi R; Mochtar CA; Junizaf ; Santoso BI; Tjahjodjati ; Purwara BH; Hardjowijoto S; Paraton H; Yunaidi DA Acta Med Indones; 2012 Jul; 44(3):214-21. PubMed ID: 22983076 [TBL] [Abstract][Full Text] [Related]
3. Overactive Bladder Symptom Scores responsiveness before and after anticholinergic treatment in women with overactive bladder: The pilot study. Bunyavejchevin S J Obstet Gynaecol Res; 2017 Jul; 43(7):1189-1193. PubMed ID: 28612999 [TBL] [Abstract][Full Text] [Related]
4. The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment. Chou EC; Hung MJ; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC J Formos Med Assoc; 2014 Aug; 113(8):506-12. PubMed ID: 25037757 [TBL] [Abstract][Full Text] [Related]
5. Reliability and validity of the overactive bladder symptom score in Hong Kong Chinese. Yiu MK; Li CM; Hou SM; Wong CW; Tam S; Chu SK Hong Kong Med J; 2013 Dec; 19(6):504-10. PubMed ID: 23787257 [TBL] [Abstract][Full Text] [Related]
6. Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response. Culha MG; Degirmentepe RB; Ozbir S; Cakir SS; Homma Y Int Urogynecol J; 2019 Dec; 30(12):2121-2126. PubMed ID: 31332467 [TBL] [Abstract][Full Text] [Related]
7. Reliability and validity of the Overactive Bladder Symptom Score in Spanish (OABSS-S). Weinberg AC; Brandeis GH; Bruyere J; Tsui JF; Weiss JP; Rutman MP; Blaivas JG Neurourol Urodyn; 2012 Jun; 31(5):664-8. PubMed ID: 22488591 [TBL] [Abstract][Full Text] [Related]
8. Reliability of the Polish version of the Overactive Bladder Symptom Score (OABSS) questionnaire : Correlation of the OABSS with urodynamic study and the UDI-6 and IIQ-7 questionnaires. Wróbel A; Skorupska K; Rechberger E; Woźniak A; Miotla P; Kubik-Komar A; Skorupski P; Rechberger T Int Urogynecol J; 2019 Dec; 30(12):2135-2139. PubMed ID: 31396639 [TBL] [Abstract][Full Text] [Related]
9. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug. Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the overactive bladder symptom score and the overactive bladder symptom score derived from the bladder diaries. Hikita KS; Honda M; Hirano S; Kawamoto B; Panagiota T; Muraoka K; Sejima T; Takenaka A Neurourol Urodyn; 2016 Mar; 35(3):349-53. PubMed ID: 25597478 [TBL] [Abstract][Full Text] [Related]
11. Psychometric validation of the English version of the overactive bladder symptom score. Homma Y; Fujimura T Urology; 2014 Jul; 84(1):46-50. PubMed ID: 24837445 [TBL] [Abstract][Full Text] [Related]
12. Reproducibility study of Overactive Bladder Symptom Score questionnaire and its response to treatment (RESORT) in Korean population with overactive bladder symptoms. Jeong SJ; Homma Y; Oh SJ Qual Life Res; 2014 Feb; 23(1):285-92. PubMed ID: 23715806 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of the Chinese Overactive Bladder Symptom Score for assessing overactive bladder syndrome in a RESORT study. Hung MJ; Chou CL; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC J Formos Med Assoc; 2013 May; 112(5):276-82. PubMed ID: 23660224 [TBL] [Abstract][Full Text] [Related]
14. Overactive bladder symptom score to evaluate efficacy of solifenacin for the treatment of overactive bladder symptoms. Liu M; Wang J; Yang Y; An R; Wen J; Guan Z; Zheng S; Wang D; Song B; Liao L; Guo H; Xiao J; Sun Y; Shen Z; Kong C; He D; Huang Y; Wang X; Zhang X; Li H; Huang J; Zhao X; Zeng P; Song X; Ye Z Chin Med J (Engl); 2014; 127(2):261-5. PubMed ID: 24438613 [TBL] [Abstract][Full Text] [Related]
15. Symptom score change and patient versus doctor satisfaction in overactive bladder before and after anti-muscarinic treatment. Bunyavejchevin S J Obstet Gynaecol Res; 2015 Jun; 41(6):957-61. PubMed ID: 25773663 [TBL] [Abstract][Full Text] [Related]
16. Symptom severity and patient perceptions in overactive bladder: how are they related? Homma Y; Gotoh M BJU Int; 2009 Oct; 104(7):968-72. PubMed ID: 19338560 [TBL] [Abstract][Full Text] [Related]
17. Should we use the shorter Thai-version quality of life and symptoms questionnaires in women with overactive bladder? Bunyavejchevin S; Liao L; Lu SH; Choo MS; Rabbani KJ; Havanond P J Obstet Gynaecol Res; 2015 Aug; 41(8):1260-5. PubMed ID: 26081949 [TBL] [Abstract][Full Text] [Related]
18. Validity and Reliability of the Thai Version of Dysfunctional Voiding Symptom Score (DVSS) Questionnaire. Piyaphanee N; Sirikuntaramas S; Sumboonnanonda A; Farhat WA J Med Assoc Thai; 2016; 100(1):9-16. PubMed ID: 29911372 [TBL] [Abstract][Full Text] [Related]
19. Psychometric Properties and Cutoff Value of the Turkish Overactive Bladder Symptom Score. Baran E; Gürşen C; Ozgul S; Çinar GN; Nakip G; Üzelpasaci E; Ozgul N; Beksaç MS; Akbayrak T Urogynecology (Phila); 2024 Aug; 30(8):691-698. PubMed ID: 38212116 [TBL] [Abstract][Full Text] [Related]
20. Correlation between overactive bladder symptom score and neuropsychological parameters in Alzheimer's disease patients with lower urinary tract symptom. Jung HB; Choi DK; Lee SH; Cho ST; Na HR; Park MH Int Braz J Urol; 2017; 43(2):256-263. PubMed ID: 27802001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]